We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+10.46%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.6B
AUM Growth
+$469M
Cap. Flow
-$728M
Cap. Flow %
-4.67%
Top 10 Hldgs %
19.64%
Holding
1,610
New
490
Increased
294
Reduced
373
Closed
440

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$141M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$127M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$109M
4
MRK icon
Merck
MRK
+$97.7M
5
ZBH icon
Zimmer Biomet
ZBH
+$80.8M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$174M
2
INTC icon
Intel
INTC
+$133M
3
IMMU
Immunomedics Inc
IMMU
+$130M
4
ABBV icon
AbbVie
ABBV
+$122M
5
NEE icon
NextEra Energy
NEE
+$108M

Sector Composition

Rank Sector Weight
1 Healthcare 27.77%
2 Technology 17.59%
3 Consumer Discretionary 13.24%
4 Industrials 9.9%
5 Financials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BERY
51
DELISTED
Berry Global Group, Inc.
BERY
$66.9M 0.43%
1,507,015
-911,095
-38% -$41.8M
FICO icon
52
Fair Isaac
FICO
$22.5B
$65.3M 0.42%
153,445
+42,029
+38% +$17.9M
DE icon
53
Deere & Co
DE
$168B
$63.5M 0.41%
286,725
+284,279
+11,622% +$54.9M
AVTR icon
54
Avantor
AVTR
$9.19B
$63.4M 0.41%
2,818,525
-621,113
-18% -$12.9M
ELV icon
55
Elevance Health
ELV
$85.5B
$62.8M 0.4%
233,976
+83,708
+56% +$22.5M
TGT icon
56
Target
TGT
$68B
$61.8M 0.4%
392,523
+386,198
+6,106% +$53M
WTW icon
57
Willis Towers Watson
WTW
$32B
$59.9M 0.38%
286,624
+58,377
+26% +$11.9M
AXTA icon
58
Axalta
AXTA
$8.17B
$59.1M 0.38%
2,665,792
-335,776
-11% -$7.78M
GRMN
59
Garmin
GRMN
$60B
$58.9M 0.38%
620,574
+346,233
+126% +$34.6M
CVS icon
60
CVS Health
CVS
$122B
$58.7M 0.38%
1,005,952
+480,872
+92% +$29.9M
GFL icon
61
GFL Environmental
GFL
$14.9B
$58.1M 0.37%
2,734,184
-416,091
-13% -$8.37M
CI icon
62
Cigna
CI
$74.6B
$56.6M 0.36%
334,154
+131,440
+65% +$23.1M
ITW icon
63
Illinois Tool Works
ITW
$84.5B
$56.5M 0.36%
292,212
+30,568
+12% +$5.81M
EXPE icon
64
Expedia Group
EXPE
$37.3B
$56.2M 0.36%
612,447
+423,501
+224% +$38.1M
NEE icon
65
NextEra Energy
NEE
$177B
$55M 0.35%
792,500
-1,559,152
-66% -$108M
CNQ icon
66
Canadian Natural Resources
CNQ
$93.8B
$54M 0.35%
6,899,571
+2,389,941
+53% +$21.5M
SGEN
67
DELISTED
Seagen Inc. Common Stock
SGEN
$53.1M 0.34%
271,099
-93,191
-26% -$15.6M
RVTY icon
68
Revvity
RVTY
$12.8B
$52M 0.33%
414,194
+411,061
+13,120% +$47.2M
BMY icon
69
Bristol-Myers Squibb
BMY
$132B
$51.1M 0.33%
846,784
+833,809
+6,426% +$50.2M
CXO
70
DELISTED
CONCHO RESOURCES INC.
CXO
$51M 0.33%
1,156,106
-46,034
-4% -$2.3M
COO icon
71
Cooper Companies
COO
$14.5B
$51M 0.33%
604,792
-263,608
-30% -$20.2M
CCXI
72
DELISTED
ChemoCentryx, Inc.
CCXI
$50.8M 0.33%
926,682
-623,452
-40% -$33.6M
HZNP
73
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$50.6M 0.32%
651,306
-465,441
-42% -$32M
ACAD icon
74
Acadia Pharmaceuticals
ACAD
$5.03B
$50.3M 0.32%
1,219,189
+1,194,767
+4,892% +$51.6M
KDP icon
75
Keurig Dr Pepper
KDP
$40.8B
$49.9M 0.32%
+1,808,999
New +$53M
1 2
3
4 5

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q3 2020 Portfolio in Review

As of Q3 2020, Marshall Wace North America held 1,610 positions worth $15.6B, up 3.1% from $15.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace North America withdrew a net $728M in Q3 2020, closing 440 positions and reducing 373 holdings. Its most notable exit was Intel, an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in Keurig Dr Pepper worth $49.9M.

  • Marshall Wace North America's largest Q3 2020 buy was Keurig Dr Pepper: 1,808,999 shares worth $49.9M.
  • Marshall Wace North America added most to Danaher in Q3 2020, an estimated $141M increase.
  • Marshall Wace North America's biggest Q3 2020 reduction was UnitedHealth, cutting an estimated $174M.
  • Marshall Wace North America fully exited Intel in Q3 2020, selling an estimated $133M.
  • Marshall Wace North America's ten largest holdings make up 20% of its $15.6B portfolio in Q3 2020.
  • Marshall Wace North America opened 490 new positions and closed 440 in Q3 2020.
  • Marshall Wace North America's portfolio value rose 3.1% quarter-over-quarter to $15.6B.

Based on Marshall Wace North America's 13F filing for Q3 2020, filed 16 Nov 2020.